Entrada Therapeutics Inc.
TRDA | NASDAQ
$6.79
+$0.15 (+2.26%)
Sep 22, 2026, 1:19 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -165.78M | -166.12M | -143.75M | -103.46M | -73.35M | 24.78M | 65.63M | 54.95M | 104.44M | 23.49M | -6.69M | -21.77M | -82.37M | -79.62M | -94.62M | -88.43M | -77.73M | -64.45M | -51.16M | -41.38M | -33.94M | -29.47M |
Depreciation & Amortization | 896K | 284K | 425K | 4.2M | 3.91M | 3.79M | 3.77M | 3.52M | 3.41M | 3.23M | 2.84M | 2.63M | 2.31M | 2.05M | 1.89M | 1.73M | 1.52M | 1.31M | 1.12M | 851K | 639K | 456K |
Stock-Based Compensation | 24.11M | 19.27M | 19.61M | 19.95M | 19.7M | 19.27M | 17.92M | 17.06M | 15.59M | 14.09M | 13.11M | 12.15M | 11.46M | 10.86M | 9.9M | 8.47M | 6.34M | 4.16M | 2.53M | 1.17M | 663K | 413K |
Other Working Capital | 1.9M | 12.07M | -5.5M | -46.4M | -72.89M | -168.27M | -122.04M | -82.95M | -125.06M | -47.13M | 138.7M | 126.73M | 183.79M | 193.79M | -16.4M | -8.64M | -6.77M | -6.36M | -2.71M | 2.02M | 3.56M | 1.12M |
Other Non-Cash Items | -919K | 790K | n/a | -5.55M | -8.02M | -9.32M | -10.02M | -9.51M | -8.15M | -7.58M | -5.78M | -3.88M | -2.06M | -227K | 152K | 176K | 361K | 216K | 74K | 166K | 13K | 172K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.79M | 14.08M | -4.8M | -43.07M | -66.1M | -93.06M | -118.85M | -79.98M | -129.49M | -122.34M | 136.32M | 127.38M | 184.18M | 197.55M | -11.11M | -8.97M | -4.11M | -4.75M | -3.42M | 2.26M | 4.11M | 1.18M |
Operating Cash Flow | -137.9M | -131.7M | -128.51M | -127.91M | -123.87M | -54.55M | -41.56M | -13.97M | -14.19M | -89.12M | 139.8M | 116.51M | 113.52M | 130.6M | -93.79M | -87.02M | -73.62M | -63.52M | -50.86M | -36.95M | -28.52M | -27.26M |
Capital Expenditures | 323K | 59K | -1.04M | -1.88M | -2.69M | -3.46M | -3.16M | -3.5M | -4.31M | -4.78M | -5.61M | -5.35M | -4.71M | -3.96M | -2.89M | -3.5M | -3.5M | -4.27M | -4.58M | -4.71M | -4.14M | -2.91M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 38.78M | 38.78M | 38.78M | 38.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -72.61M | -73.42M | -141.61M | -187.64M | -326.66M | -420.8M | -437.72M | -461.74M | -372.94M | -402.37M | -407.21M | -318.69M | -281.22M | -141.1M | -221.98M | -221.98M | -182.65M | -182.65M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 220.63M | 212.37M | 259.46M | 330.57M | 338.38M | 375.1M | 413.08M | 403.12M | 394.32M | 335.35M | 274.43M | 185.39M | 140.89M | 137.5M | 76.21M | 56.71M | 26.71M | 1.71M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -38.78M | -38.78M | -38.78M | -38.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.5K |
Investing Cash Flow | 148.34M | 139.01M | 116.81M | 141.05M | 9.02M | -49.16M | -27.8M | -62.12M | 17.07M | -71.8M | -138.4M | -138.65M | -145.04M | -7.56M | -148.65M | -168.76M | -159.44M | -185.21M | -4.58M | -4.71M | -4.14M | -2.91M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 320K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 350K | n/a | n/a | n/a | 381K | 1.75M | 1.75M | 1.75M | 1.37M | n/a | 129K | 129K | 129K | 129K | n/a | n/a | n/a | 632K | 769K | 918K | 918K | 12.82M |
Financial Cash Flow | 870K | 637K | 887K | 2.1M | 2.08M | 103.11M | 102.96M | 102.25M | 102.63M | 1.71M | 21.04M | 20.71M | 20.4M | 19.97M | 479K | 190.88M | 190.92M | 191.13M | 307.46M | 116.86M | 141.61M | 153.94M |
Net Cash Flow | 11.31M | 7.95M | -10.82M | 15.24M | -112.77M | -599K | 33.61M | 26.17M | 105.51M | -159.21M | 22.45M | -1.43M | -11.12M | 143.01M | -241.96M | -64.91M | -42.13M | -57.6M | 252.02M | 75.2M | 108.96M | 123.77M |
Free Cash Flow | -137.58M | -131.64M | -129.55M | -129.8M | -126.56M | -58.01M | -44.72M | -17.46M | -18.5M | -93.9M | 134.19M | 111.17M | 108.81M | 126.64M | -96.67M | -90.52M | -77.11M | -67.78M | -55.44M | -41.65M | -32.66M | -30.17M |
Adj. Free Cash Flow | -161.69M | -150.91M | -149.16M | -149.75M | -146.26M | -77.28M | -62.63M | -34.52M | -34.09M | -107.99M | 121.08M | 99.01M | 97.35M | 115.79M | -106.57M | -99M | -83.46M | -71.94M | -57.97M | -42.82M | -33.32M | -30.58M |
Maintenance CapEx | 323K | 59K | -1.04M | -1.88M | -2.69M | -2.42M | -1.27M | -639K | n/a | n/a | n/a | -525K | -1.04M | -1.5M | -1.89M | -1.73M | -1.52M | -1.31M | -1.12M | -851K | -639K | -456K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | -1.05M | -1.88M | -2.86M | -4.31M | -4.78M | -5.61M | -4.82M | -3.67M | -2.46M | -993K | -1.77M | -1.98M | -2.96M | -3.46M | -3.86M | -3.5M | -2.46M |
Owner Earnings | -137.58M | -131.64M | -129.55M | -129.8M | -126.56M | -56.96M | -42.83M | -14.6M | -14.19M | -89.12M | 139.8M | 115.99M | 112.48M | 129.1M | -95.68M | -88.76M | -75.14M | -64.83M | -51.98M | -37.8M | -29.15M | -27.71M |
Add to Watchlist
Select watchlists to add or remove TRDA